Platelet-Derived Microparticles

Platelets

Volumn , Issue , 2013, Pages 453-467

  Nieuwland, Rienk ^a   van der Pol, Edwin ^a   Gardiner, Chris ^b   Sturk, Auguste ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882644475     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387837-3.00022-5     Document Type: Chapter

References (101)

1. Chargaff E., West R. The biological significance of the thromboplastic protein of blood. J Biol Chem 1946, 166(1):189-197.
2. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13(3):269-288.
3. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94(11):3791-3799.
4. Heijnen H.F., Debili N., Vainchencker W., Breton-Gorius J., Geuze H.J., Sixma J.J. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998, 91(7):2313-2325.
5. Schroit A.J., Zwaal R.F. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991, 1071(3):313-329.
6. Bevers E.M., Comfurius P., Dekkers D.W., Zwaal R.F. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta 1999, 1439(3):317-330.
7. Bevers E.M., Comfurius P., Zwaal R.F. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983, 736(1):57-66.
8. Chang C.P., Zhao J., Wiedmer T., Sims P.J. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993, 268(10):7171-7178.
9. Zwaal R.F., Comfurius P., Bevers E.M. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004, 1636(2-3):119-128.
10. Zhou Q., Zhao J., Wiedmer T., Sims P.J. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 2002, 99(11):4030-4038.
11. Connor D.E., Exner T., Ma D.D., Joseph J.E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010, 103(5):1044-1052.
12. Flaumenhaft R., Dilks J.R., Richardson J., Alden E., Patel-Hett S.R., Battinelli E., et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009, 113(5):1112-1121.
13. van der Zee P.M., Biro E., Ko Y., de Winter R.J., Hack C.E., Sturk A., et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006, 52(4):657-664.
14. DasGupta S.K., Abdel-Monem H., Niravath P., Le A., Bellera R.V., Langlois K., et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009, 113(6):1332-1339.
15. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989, 264(29):17049-17057.
16. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., Hunt D.F. The platelet microparticle proteome. J Proteome Res 2005, 4(5):1516-1521.
17. van der Pol E., Hoekstra A.G., Sturk A., Otto C., van Leeuwen T.G., Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010, 8(12):2596-2607.
18. Lacroix R., Robert S., Poncelet P., Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010, 36(8):807-818.
19. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., Maquelin K.N., Roozendaal K.J., Jansen P.G., et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997, 96(10):3534-3541.
20. Berckmans R.J., Nieuwland R., Boing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85(4):639-646.
21. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95(3):930-935.
22. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104(1):93-102.
23. Lacroix R., Robert S., Poncelet P., Kasthuri R.S., Key N.S., Dignat-George F. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010, 8(11):2571-2574.
24. Chandler W.L., Yeung W., Tait J.F. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 2011, 9(6):1216-1224.
25. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009, 15(22):6830-6840.
26. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J.L., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997, 99(7):1546-1554.
27. Nomura S., Shouzu A., Taomoto K., Togane Y., Goto S., Ozaki Y., et al. Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb 2009, 16(6):878-887.
28. Miyamoto S., Marcinkiewicz C., Edmunds L.H., Niewiarowski S. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa. Thromb Haemost 1998, 80(2):225-230.
29. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J., Hole P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 2011, 7(6):780-788.
30. Yuana Y., Oosterkamp T.H., Bahatyrova S., Ashcroft B., Garcia R.P., Bertina R.M., et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010, 8(2):315-323.
31. Jy W., Horstman L.L., Jimenez J.J., Ahn Y.S., Biro E., Nieuwland R., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2(10):1842-1851.
32. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996, 88(9):3456-3464.
33. Holme P.A., Orvim U., Hamers M.J., Solum N.O., Brosstad F.R., Barstad R.M., et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997, 17(4):646-653.
34. Gemmell C.H., Ramirez S.M., Yeo E.L., Sefton M.V. Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 1995, 125(2):276-287.
35. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988, 263(34):18205-18212.
36. Bode A.P., Knupp C.L. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994, 34(8):690-696.
37. Fox J.E., Austin C.D., Reynolds C.C., Steffen P.K. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991, 266(20):13289-13295.
38. Kelton J.G., Moore J.C., Warkentin T.E., Hayward C.P. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura. Br J Haematol 1996, 93(2):421-426.
39. Wiedmer T., Shattil S.J., Cunningham M., Sims P.J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990, 29(3):623-632.
40. George J.N., Thoi L.L., McManus L.M., Reimann T.A. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982, 60(4):834-840.
41. Gemmell C.H., Sefton M.V., Yeo E.L. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993, 268(20):14586-14589.
42. Holme P.A., Solum N.O., Brosstad F., Egberg N., Lindahl T.L. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. Thromb Haemost 1995, 74(6):1533-1540.
43. Siljander P., Carpen O., Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996, 87(11):4651-4663.
44. Rodmam N.F., Painter J.C., McDevitt N.B. Platelet disintegration during clotting. J Cell Biol 1963, 16:225-241.
45. Ramacciotti E., Hawley A.E., Farris D.M., Ballard N.E., Wrobleski S.K., Myers D.D., et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009, 101(4):748-754.
46. Bode A.P., Orton S.M., Frye M.J., Udis B.J. Vesiculation of platelets during in vitro aging. Blood 1991, 77(4):887-895.
47. Shcherbina A., Rosen F.S., Remold-O'Donnell E. Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol 1999, 106(4):875-883.
48. Wolf B.B., Goldstein J.C., Stennicke H.R., Beere H., Amarante-Mendes G.P., Salvesen G.S., et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999, 94(5):1683-1692.
49. Sebbagh M., Renvoize C., Hamelin J., Riche N., Bertoglio J., Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001, 3(4):346-352.
50. Boing A.N., Hau C.M., Sturk A., Nieuwland R. Platelet microparticles contain active caspase 3. Platelets 2008, 19(2):96-103.
51. Wiedmer T., Hall S.E., Ortel T.L., Kane W.H., Rosse W.F., Sims P.J. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993, 82(4):1192-1196.
52. Hugel B., Socie G., Vu T., Toti F., Gluckman E., Freyssinet J.M., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999, 93(10):3451-3456.
53. Cramer E.M., Norol F., Guichard J., Breton-Gorius J., Vainchenker W., Masse J.M., et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997, 89(7):2336-2346.
54. Rank A., Nieuwland R., Delker R., Pihusch V., Wilkowski R., Toth B., et al. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant 2011, 25(3):E233-E242.
55. Lee K.D., Hong K., Papahadjopoulos D. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim Biophys Acta 1992, 1103(2):185-197.
56. Lemke G, Burstyn-Cohen T. TAM receptors and the clearance of apoptotic cells. Ann NY Acad Sci 2010, 1209:23-29.
57. Rank A., Nieuwland R., Crispin A., Grutzner S., Iberer M., Toth B., et al. Clearance of platelet microparticles in vivo. Platelets 2011, 22(2):111-116.
58. van den Goor J.M., Nieuwland R., Rutten P.M., Tijssen J.G., Hau C., Sturk A., et al. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. Eur J Cardiothorac Surg 2007, 31(6):1029-1036.
59. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005, 106(5):1604-1611.
60. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W., Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002, 106(19):2442-2447.
61. Tans G., Rosing J., Thomassen M.C., Heeb M.J., Zwaal R.F., Griffin J.H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991, 77(12):2641-2648.
62. Taube J., McWilliam N., Luddington R., Byrne C.D., Baglin T. Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 1999, 93(11):3792-3797.
63. Joop K., Berckmans R.J., Nieuwland R., Berkhout J., Romijn F.P., Hack C.E., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001, 85(5):810-820.
64. Merten M., Pakala R., Thiagarajan P., Benedict C.R. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999, 99(19):2577-2582.
65. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000, 95(4):1317-1323.
66. Barry O.P., Kazanietz M.G., Pratico D., FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999, 274(11):7545-7556.
67. Barry O.P., Pratico D., Lawson J.A., FitzGerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997, 99(9):2118-2127.
68. Iwamoto S., Kawasaki T., Kambayashi J., Ariyoshi H., Monden M. Platelet microparticles: a carrier of platelet-activating factor?. Biochem Biophys Res Commun 1996, 218(3):940-944.
69. Boulanger C.M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001, 104(22):2649-2652.
70. VanWijk M.J., Svedas E., Boer K., Nieuwland R., Vanbavel E., Kublickiene K.R. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002, 187(6):1686-1693.
71. Pfister S.L. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004, 43(2):428-433.
72. Celi A., Pellegrini G., Lorenzet R., De B.A., Ready N., Furie B.C., et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994, 91(19):8767-8771.
73. Nagalla S., Shaw C., Kong X., Kondkar A.A., Edelstein L.C., Ma L., et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011, 117(19):5189-5197.
74. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3(11):e3694.
75. Biro E., Nieuwland R., Tak P.P., Pronk L.M., Schaap M.C., Sturk A., et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 2007, 66(8):1085-1092.
76. Kim H.K., Song K.S., Chung J.H., Lee K.R., Lee S.N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004, 124(3):376-384.
77. Weber A., Koppen H.O., Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000, 98(5):461-466.
78. Mause S.F., Ritzel E., Liehn E.A., Hristov M., Bidzhekov K., Muller-Newen G., et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010, 122(5):495-506.
79. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327(5965):580-583.
80. Weiss H.J., Vicic W.J., Lages B.A., Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979, 67(2):206-213.
81. Toti F., Satta N., Fressinaud E., Meyer D., Freyssinet J.M. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996, 87(4):1409-1415.
82. Dachary-Prigent J., Pasquet J.M., Fressinaud E., Toti F., Freyssinet J.M., Nurden A.T. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br J Haematol 1997, 99(4):959-967.
83. Bettache N., Gaffet P., Allegre N., Maurin L., Toti F., Freyssinet J.M., et al. Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome. Br J Haematol 1998, 101(1):50-58.
84. Castaman G., Yu-Feng L., Battistin E., Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997, 96(3):458-463.
85. Jy W., Horstman L.L., Arce M., Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992, 119(4):334-345.
86. Lee Y.J., Jy W., Horstman L.L., Janania J., Reyes Y., Kelley R.E., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993, 72(4):295-304.
87. Nomura S., Komiyama Y., Miyake T., Miyazaki Y., Kido H., Suzuki M., et al. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994, 72(4):519-522.
88. Warkentin T.E. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev 1996, 10(4):249-258.
89. Warkentin T.E., Hayward C.P., Boshkov L.K., Santos A.V., Sheppard J.A., Bode A.P., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994, 84(11):3691-3699.
90. Morel O., Jesel L., Chauvin M., Freyssinet J.M., Toti F. Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome. J Thromb Haemost 2003, 1(12):2685-2687.
91. Biro E., Sturk-Maquelin K.N., Vogel G.M., Meuleman D.G., Smit M.J., Hack C.E., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003, 1(12):2561-2568.
92. McGill M., Fugman D.A., Vittorio N., Darrow C. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med 1987, 109(2):127-133.
93. Nomura S., Suzuki M., Katsura K., Xie G.L., Miyazaki Y., Miyake T., et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995, 116(2):235-240.
94. Larsson A., Nilsson B., Eriksson M. Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila infection. Thromb Res 1999, 96(5):391-397.
95. Nomura S., Shouzu A., Nishikawa M., Kokawa T., Yasunaga K. Significance of platelet-derived microparticles in uremia. Nephron 1993, 63(4):485.
96. Wun T., Paglieroni T., Rangaswami A., Franklin P.H., Welborn J., Cheung A., et al. Platelet activation in patients with sickle cell disease. Br J Haematol 1998, 100(4):741-749.
97. Horstman L.L., Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999, 30(2):111-142.
98. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011, 108(10):1284-1297.
99. Berckmans R.J., Sturk A., van Tienen L.M., Schaap M.C., Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 2011, 117(11):3172-3180.
100. George J.N., Pickett E.B., Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986, 68(1):307-309.
101. Chao F.C., Kim B.K., Houranieh A.M., Liang F.H., Konrad M.W., Swisher S.N., et al. Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets. Transfusion 1996, 36(6):536-542.